Ieq Capital LLC Grows Stock Holdings in Haleon plc (NYSE:HLN)

Ieq Capital LLC raised its stake in Haleon plc (NYSE:HLN) by 16.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 28,251 shares of the company’s stock after buying an additional 4,079 shares during the quarter. Ieq Capital LLC’s holdings in Haleon were worth $270,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of HLN. Private Advisor Group LLC boosted its position in shares of Haleon by 7.2% in the 4th quarter. Private Advisor Group LLC now owns 51,724 shares of the company’s stock worth $493,000 after buying an additional 3,490 shares in the last quarter. Atria Wealth Solutions Inc. lifted its holdings in shares of Haleon by 6.1% in the fourth quarter. Atria Wealth Solutions Inc. now owns 47,868 shares of the company’s stock valued at $457,000 after purchasing an additional 2,758 shares in the last quarter. Nicholas Hoffman & Company LLC. purchased a new stake in shares of Haleon in the fourth quarter valued at about $146,000. Sierra Ocean LLC acquired a new stake in shares of Haleon in the fourth quarter valued at approximately $26,000. Finally, Allworth Financial LP increased its stake in shares of Haleon by 31.8% during the 4th quarter. Allworth Financial LP now owns 9,884 shares of the company’s stock worth $90,000 after purchasing an additional 2,383 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Stock Performance

Shares of HLN opened at $10.18 on Friday. Haleon plc has a 1 year low of $7.89 and a 1 year high of $10.80. The company’s 50 day simple moving average is $9.59 and its 200 day simple moving average is $9.83. The company has a market capitalization of $46.06 billion, a price-to-earnings ratio of 29.93, a PEG ratio of 2.82 and a beta of 0.28. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.

Haleon (NYSE:HLN) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The company had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. On average, sell-side analysts predict that Haleon plc will post 0.43 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the company. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.